Form 8-K - Current report:
SEC Accession No. 0000950137-04-007416
Filing Date
2004-09-01
Accepted
2004-09-01 15:19:59
Documents
2
Period of Report
2004-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT c87979e8vk.htm 8-K 12792
2 SECOND AMENDMENT TO LEASE c87979exv10w1.htm EX-10.1 8848
  Complete submission text file 0000950137-04-007416.txt   23497
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 041011050
SIC: 2836 Biological Products, (No Diagnostic Substances)